The safety of homeopathic products
It is regrettable that Professor Kirby's editorial (May 2002 JRSM 1 ) did not mention a review of this topic conducted and published by us 2 . This was a formal systematic review using prospectively defined inclusion and exclusion criteria and data extraction procedures. It comprised a review of English-language publications and enquiries with manufacturers and regulatory agencies. Table 1 shows a sample of the data: in therapeutic clinical trials (as opposed to healthy-volunteer homeopathic pathogenetic trials) the incidence of reported adverse effects (AEs) is higher in the verum group than in the placebo group (mean incidence 9.4/6.1).
The conclusions were based on these data and reports of apparent AEs from homeopathic pathogenetic trials (provings) and case reports. The main conclusions were:
. Homeopathic medicines may provoke AEs, but these are generally mild and transient . There is under-reporting . There are cases of 'mistaken identity', where herbal and other medicines were described as homeopathic . The main risks associated with homeopathy are indirect, relating to the prescriber rather than the medicine.
Although strictly speaking outside the remit of the editorial, the last point is particularly important. Not only is it the main risk of homeopathy, but it is a topical issue. Medical practice in the UK is currently essentially unregulated; anybody, irrespective of training or registration, can describe themselves as a homeopath. This is the main preventable source of risk. In their evidence to the House of Lords Select Committee on Complementary and Alternative Medicine 3 , bodies representing non medically qualified acupuncturists and herbalists stated that their professions wished to become statutorily regulated, the Select Committee's report endorsed this view, and the process towards statutory regulation of these professions is now underway.
The non-medical homeopaths, however, indicated that they did not currently wish statutory regulation, despite the view of the Faculty of Homeopathy (doctors and other health professionals practising homeopathy) that homeopathy should be practised only by statutorily registered away from in my editorial-namely, the paucity and quality of data; and the regulation of homeopaths.
Their survey shows how relatively few adverse events have been reported. As they point out, this might be due to under-reporting; or it might reflect the high dilution of homeopathic remedies. I suspect both explanations are correct. The data on which they based their article and letter illustrate the quality of reports pervading much of the published work on homeopathy: they fail to achieve the standards now expected in pharmacovigilance reporting. In order to gain truly sound, objective, data they need to set up a prospective survey, based on pharmacoepidemiological principles, with sufficient statistical power to yield a useful conclusion. Until this has been done the uncertainty I alluded to in my editorial, and as illustrated by their review, will remain.
They raise the question of regulating homeopathy. This opens an important subject extending beyond the scope of a short editorial. The fact remains that there are non-medical homeopaths in practice many of whom have been through training programmes. For those who have not done so, their detailed knowledge about disease is questionable bringing with it the attendant problem that they may sometimes miss a diagnosis where early intervention by a medical practitioner would reduce suffering or even, on occasion, 
